Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
214.60
-0.70 (-0.33%)
Jun 10, 2026, 3:10 PM AST
TADAWUL:4013 Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, TADAWUL:4013 stock has a consensus rating of "Buy" and an average price target of SAR 274.11. The average 1-year stock price forecast is 27.73% higher than the current stock price, while the lowest is SAR 181.00 (-15.66%) and the highest is SAR 320.00 (+49.11%).
Price Target: SAR 274.11 (+27.73%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4013 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 8 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 3 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Total | 12 | 12 | 12 | 13 | 14 | 14 |
Financial Forecast
Revenue This Year
15.69B
from 13.71B
Increased by 14.43%
Revenue Next Year
17.58B
from 15.69B
Increased by 12.11%
EPS This Year
7.43
from 6.86
Increased by 8.38%
EPS Next Year
9.10
from 7.43
Increased by 22.35%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.1B | ||
| Avg | 15.7B | ||
| Low | 15.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.1% | ||
| Avg | 14.4% | ||
| Low | 11.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 7.43 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 8.4% | ||
| Low | - |